New Markets, New Challenges: Ethical and Regulatory Hurdles Facing the International Pharmaceutical and Medical Device Industry

Presented by: School of Business Administration and Miller School of Medicine

	Sponsored by:

While quality health care has lagged in many developing nations in Latin America, Eastern Europe and Asia, these markets have become increasingly popular for pharmaceutical products and medical devices. However, the growth of these industries has been accompanied by tough ethical, regulatory and compliance related challenges. There is now serious concern that these challenges could impede the benefits that a robust pharmaceutical and medical device marketplace could bring to these markets.

This panel will explore the opportunities that have arisen worldwide and offer solutions to help organizations meet the challenges they face as they enter new markets. 

• Carlos Alonso, President, Renal, Baxter Healthcare Corp.
• Clivetty Martinez, Vice President, Global Healthcare Compliance and Privacy, Latin America, Johnson & Johnson

• Rogerio Ribeiro, President, Latin America and Caribbean, GlaxoSmithKline

• Kenneth Goodman, Professor of Medicine and Philosophy and Co-Director, Ethics Programs, University of Miami (moderator)

From Out of the Blue: Catching the Next Wave in Health Care

Presented by: Rosenstiel School of Marine and Atmospheric Science
As the Gulf Coast struggles with the consequences of the worst offshore oil spill in U.S. history, the significant role that coastal zones and oceans play in the overall health of our planet and society has taken center stage. But not only are our oceans a resource for fuel, food and jobs as we have been reminded, there is increasing evidence that they can play a significant role in medicine. Ocean and human health researchers have identified a range of benefits to humans from the world's oceans, and growing evidence suggests that access to the natural environment may improve health and wellbeing, prevent disease and help people recover from illness. This panel will explore how this emerging discipline is translating into new approaches and new opportunities in preventative health care – from out of the blue.

• Michael H. Depledge, Chair of Environmental and Human Health, Peninsula Medical School, Devon, UK
• Richard Fain, Chairman and CEO, Royal Caribbean Cruises Ltd.
• Lora Fleming, MD, Professor of Epidemiology & Public Health and Marine Biology & Fisheries, Miller School of Medicine and Co-Director, NSF-NIEHS Oceans and Human Health Center, Rosenstiel School of Marine and Atmospheric Sciences, University of Miami
• Nicolas Ibarguen, Publisher, PODER Magazine
• Sharon Smith, Co-Director, NSF-NIEHS Oceans and Human Health Center, Rosenstiel School of Marine and Atmospheric Science, University of Miami
• Roni Avissar, Dean, Rosentiel School of Marine and Atmospheric Science (opening remarks)

Meeting the Global Health Care Challenge: The Role of Nursing

Presented by: School of Nursing and Health Studies
With the rapid advance of science leading to longer life and an aging baby-boomer generation, the number of patients who need care is burgeoning and will continue to do so around the world. The health care system of today will not be able to keep up with the demand.  More nurses with advanced second and third degrees will be needed to provide advanced patient care. This panel will provide insight into the new opportunities arising from this demand and offer solutions for delivering the global preparation, training and advanced degree programs required to enable nursing to meet the challenges facing global health care.

• Rosemary Bryant, President, International Council of Nurses

• Linda Burnes Bolton, Vice President and Chief Nursing Officer, Cedars-Sinai Health System

• Afaf Meleis, Dean, School of Nursing, University of Pennsylvania

• Donna E. Shalala, President University of Miami (moderator)

The Future of Pharma: Pharmaceutical Innovation, Competition and Pricing   

Presented by: School of Business Administration
The pharmaceutical industry in the U.S. and Europe has entered the mature or “competitive stage” of its industry lifecycle. With fewer new products, stagnant markets, price ceilings, and increasing brand and generic competition, multi-national companies are fighting an increasingly intense battle for stakeholder mindshare, product sales, and corporate survival. This panel will look at present and future pharmaceutical industry scenarios and key trends including decreasing innovation; R&D outsourcing, payer pressures; pressures for novel access, pricing, and contracting; greater brand competition; commercial approaches to generics; enhanced stakeholder scrutiny; the consumerization of pharmaceuticals; media challenges; and tainted industry reputation.

• Fred Hassan, Partner, Warburg Pincus, Chairman Bausch + Lomb, and Former Chairman and CEO, Schering-Plough Corporation
• Adrian Thomas, MD, FRACP, World Wide Vice President Market Access, Global Strategic Marketing and Market Access, Johnson & Johnson Pharmaceutical Services LLC
• Norbert G. Riedel, Corporate Vice President and Chief Scientific Officer, Baxter International Inc.

• Michael R. Williams, Senior Vice President, Worldwide New Products, Pfizer Inc.

• Stan Bernard, MD, President, Bernard Associates (moderator)

Advances in Integrative Healthcare: Impact on Global Health Issues

Presented by: School of Nursing and Health Studies

Integrative Health Care has been the subject of rigorous research for more than 40-years, exploring the relationship emotional health plays on a patient’s total health.  Advocates of Integrative Health Care, point to research that show how anxiety, depression and fear have a direct impact on the digestive system’s function.  Proponents reference a correlation between social and psychological stress and how it can aggravate a wide variety of diseases, including diabetes, and high blood pressure; and how activities such as meditation, yoga, tai chi and social support improve total health.  Others question both the value of Integrative Health Care and the science and research. This panel will evaluate the facts and fiction associated with this controversial form of patient care, and the role it will play in the future of global health care.

• Todd Ambrosia, Assistant Professor, Clinical, School of Nursing and Health Studies, University of Miami
• Susan Luck, National Director, Integrative Nursing Institute

• Maria Lamas Shojaee, Trustee, University of Miami
• Nilda Peragallo, Dean, School of Nursing and Health Studies, University of Miami (moderator)

Medical Tourism: Global Challenges and Opportunities

Presented by: School of Business Administration
The provision of health care is increasingly moving into the global marketplace. Americans continue to seek low-cost quality care in alternative markets such as Latin America, India, and Thailand. In turn, individuals living overseas seek high-tech specialties in the Unites States not available in their home country. This panel will explore the opportunities and challenges with the provision of care in a global marketplace.

• Scott Edelstein, Partner, Squire Sanders & Dempsey LLP
• William Ruschhaupt, MD, Chair, Global Patient Services, Cleveland Clinic

• Michael A. Stein, Corporate Vice President, International Division, Baptist Health South Florida
• Renee-Marie Stephano, President, Medical Tourism Association (moderator)

Disaster Preparedness, Pandemics, Natural and Man-Made Disasters

Presented by: School of Business Administration and College of Arts and Sciences
Health care pandemics, natural disasters and human-caused catastrophes can overwhelm entire nations and jeopardize the future of businesses and other organizations. This session will examine state- of-the- art responses to such human crises that now being implemented around the world. Panelists will offer insight gained from recent disasters to help governments, businesses and individuals better prepare for human crises of the future.

• William Blumentals, Global Head of Epidemiology for Virology and Transplant, Hoffman-La Roche Inc.
• Col. Doug Lougee, MD, U.S. Southern Command
• Sally Phillips, Deputy Director, Health Resilience Division, Office of Health Affairs, U.S. Department of Homeland Security

• Rafael E. Campo, MD, Professor of Clinical Medicine, Division of Infectious Diseases, Miller School of Medicine, University of Miami (moderator)

Views From the CSIS Commisssion on Smart Global Health Policy

Presented by: School of Communication

The Center for Strategic and International Studies Commission on Smart Global Health Policy works to develop actionable recommendations for a long-term U.S. strategy to enhance global health. Its guiding premise is that investments in health have rising foreign policy, security, economic and development implications that affect long-term U.S. national interests. This panel will explore the business sector's special strengths in advancing global health through systems design, accountability, innovation and communications.

• Rhona Applebaum, Vice President and Chief Scientific and Regulatory Officer, The Coca-Cola Company

• Steven C. Phillips, MD, Medical Director, Global Issues and Projects, Exxon Mobil Corporation

• James B. Peake, MD, Former U.S. Secretary of Veterans Affairs

• J. Stephen Morrison, Senior Vice President and  Director of the Center on Global Health Policy, Center for Strategic and International Studies
• Laurie S. Silvers, President, Hollywood Media Corporation and University of Miami Trustee (welcome remarks)
• Donna E. Shalala, President, University of Miami (moderator)